Medical Supplies and Equipment Businesses for Sale and Investment

Bangkok-based private limited company, established 5 years ago, is a dynamic and forward-thinking scientific distributor focused on distributing lab equipment, chemicals, biotech R&D services, and herbal health products. - The company has primarily been involved in importing and distribution, mainly sourcing products from the USA and China, and is now ready to transition into becoming manufacturer and exporter. - They are proud to be authorized distributors of world-renowned brands such as Sino Biological, FineTest, TargetMol, ELK Biotechnology, Reed Biotech, and BioBase, ensuring clients access to globally recognized products at competitive prices. - The company's mission is to bridge science with innovation by providing high-quality laboratory equipment, biological reagents, and herbal-based health products to research institutions, healthcare providers, universities, and the broader scientific community. - With previous annual sales of approximately THB 2 million and recent monthly sales of THB 429k, the business maintains a strong EBITDA margin of over 40%. - We now seek investment to scale operations by building a new GMP-compliant factory in Suphanburi province, to expand production capabilities and meet the rising global demand for natural and scientific products. - In the next year, operations will expand with a GMP-compliant factory focused on manufacturing herbal medicines, natural extracts, food and cosmetic ingredients, aligning with global quality and safety standards. - For the new GMP factory, we plan to buy land and construct a new facility on 9 rai of land in Suphanburi province. The company plans to start with a small-scale project, allowing for scalability in the future. - The company holds key licenses, including: 1. Food import license. 2. Cosmetic import license. 3. Medical device import license. Most importantly, we hold a Thai Traditional Medicine license, which is essential for establishing and running a Thai herbal factory. - Led by a visionary founder, the company offers strategic, silent, or foreign investment roles, providing opportunities for high returns and international expansion. We are committed to: 1. Supporting scientific research and education. 2. Promoting natural health innovation. 3. Offering outstanding service with local insight and global quality. The company aims to become a trusted partner in advancing science, health, and sustainability, locally and internationally.

Our well established orthopedic center currently caters to 15 patients daily. - We were certified in 2021 by the Ministry of Health and we have treated 3500 clients so far. - In Colombia, 95% of the people are insured, healthcare insurance companies pay for the services and our products. - We are the only clinic active in the whole province and aim to create better access to care in other regions of the country as well, decentralizing and professionalizing care. The business model: - Our orthopedic care centers in Colombia are franchisee branches and have paid a one-time brand fee. - We have received a subsidy from the Dutch government and 2 donations from NGOs. - We received equity from a public-private fund and from an individual investor.

The business is focused on the research, development, and commercialization of infusion bag-based products. - We have developed a line of medical infusion bags designed to simplify the medication preparation process by eliminating the need to transfer medication from vial to bottle. - This closed system lowers the risk of contamination during setup and administration. - The infusion bags have already been successfully introduced in markets outside of India, including the United States, - We aim to be the first to notice the market gap in India and introduce this device while simultaneously tapping into international markets. - Already generated significant interest from international markets such as Brazil, Vietnam, Dubai, Bahrain, Ecuador and other countries. - The business is well-prepared with approximately 10 products across various therapeutic categories, including antifungal and antibiotics, and holds the necessary drug license for research and development. - The company is seeking investment to establish a manufacturing plant, with an estimated cost of INR 125 crores, to facilitate the commercialization of their products. - The promoter of the business holds a PhD in pharmaceuticals and has over 14 years of experience in the pharmaceutical industry, including roles with top firms and a background in consulting. - Also has a wide network connectivity with more than 4k followers on LinkedIn.

The business is focused on the research, development, and commercialization of infusion bag-based products. - We have developed a line of medical infusion bags designed to simplify the medication preparation process by eliminating the need to transfer medication from vial to bottle. - This closed system lowers the risk of contamination during setup and administration. - The infusion bags have already been successfully introduced in markets outside of India, including the United States, - We aim to be the first to notice the market gap in India and introduce this device while simultaneously tapping into international markets. - Already generated significant interest from international markets such as Brazil, Vietnam, Dubai, Bahrain, Ecuador and other countries. - The business is well-prepared with approximately 10 products across various therapeutic categories, including antifungal and antibiotics, and holds the necessary drug license for research and development. - The company is seeking investment to establish a manufacturing plant, with an estimated cost of INR 125 crores, to facilitate the commercialization of their products. - The promoter of the business holds a PhD in pharmaceuticals and has over 14 years of experience in the pharmaceutical industry, including roles with top firms and a background in consulting. - Also has a wide network connectivity with more than 4k followers on LinkedIn.

Recognized by Ukraine, South Africa, and Middle East medical workers as the premier vascular technology. - We are rapidly finalizing distribution agreements worldwide. - Our year-over-year increase in the number of our distributors is 100%. - Our technology is more cost-effective than those of our competitors. - Our patented IP, and existing distributor network, have tremendous value. - We have not yet found a patient, no matter how sick, where our device could not find veins. We are moving forward with advancing the technology ever further. We have signed an agreement to advance the Vein-Eye Carry into a proactive diagnostic tool through Artificial Intelligence. We will also be releasing a smaller version that is less expensive and wearable. This is very exciting to the military as it will be used on the front lines. The AI press release is attached. The improvements will include automated hemorrhage detection, detecting changes in tissue density and fluid accumulation, identifying internal bleeding post-surgery, predictive analytics for cosmetic surgery such as "risk heat maps" based on vascular patterns to reduce the likelihood of hematomas, enhanced biometric accuracy, and layering algorithms to detect bleeding in tissue post-surgery.

Here's a revised version of the text: - A reputable distributor of medical supplies with over 20 active clients. - The company has a long-standing tradition of providing exceptional medical devices in Slovenia and Croatia, known for their outstanding performance and quality. - The company offers a wide range of high-quality products, including balloon catheters, stents, cerebral protection devices, guide wires, embolization, and miscellaneous accessories. - The company has a stable business model and enjoys a well-known client base with many positive references. - Given its current position, the company is poised for continued growth and expansion of its services.

The company is a leading disposable syringe manufacturing plant based in Akola, Maharashtra. - Specializes in producing a range of disposable surgical syringes (2ml, 3ml, 5ml, 10ml), 20ml, 50ml, with plans to diversify into IV sets, IV cannulas through third-party manufacturing, enhancing product portfolio. - Boasts a robust distribution network spanning over 4 states with more than 100 distributors and super-stockists, significantly extending its market reach. - The plant operates at a current production capacity of 1 crore syringes per month, with the capability to expand to 1.5 crore units, effectively meeting rising demands. - Complies with MD 5 License, MSME, and GST certifications, underlining a strong commitment to quality standards and regulatory requirements. - Focuses on distributor-based sales strategies, optimizing supply chain efficiency and product availability across various geographies. - Positioned for growth and product diversification within India's growing medical supplies sector, tapping into relevant distribution networks and market opportunities. - It took us around 3–4 months to obtain the necessary government approvals, during which we were unable to manufacture at full capacity or generate significant sales. Now that all required licenses have been secured, we are operating efficiently, leading to a notable increase in our monthly sales.

Our company manufactures and supplies surgical and disposable face masks under our own proprietary brand name. - We purchase raw materials from Reliance. There is no explicit contract with them. - Our company sells the product to 3 companies and two distributors. The distributors further sells and distributes them to different pharmacies and supermarkets across Tamil Nadu, Bangalore and Hyderabad. We do not possess a contract with either of them. There is no other direct clientele barring a few companies and the two distributors. - The manufacturing unit has a capacity to produce over 1.5 lakh masks per day. However, we currently use around 70 percent of the full production capacity. - This transaction includes the entire business entity, physical assets, trademarks and rights to the brand name, ISO certificate and export licenses.

We're dedicated to provide the very best of products, with an emphasis on quality products. - The production capacity is 20 - 25 units per month. - We manufacture a total of 74 different medical products. - Business has served around 340+ hospitals for the delivery of different medical products. - The business is following government regulations and keeping the margin at the said rate, after the full completion of the plant, the business can rework on the margin and increase its valuation. - The promoter has 10 years of experience in the hospital equipment business.

Our company has developed an acupressure chair to help patients revive from health problems through innovative pressure points integrated in the chair. Our technology is patented and we have provided services to more than 70 patients till date. Have developed this chair with 3 years of extensive R&D. Our business model is to provide consulting service and then sell the chair to each patient. Since we are a startup, we have only provided acupressure service till date and have not yet sold a chair. However, we have received booking for 25 chairs (yet to be sold). We will outsource the manufacturing process to a manufacturer. Seeking funds to promote our brand and give orders to the 3rd party manufacturer to produce chairs. Founder of the company is a therapist by profession and holds 15+ years of experience. Business owned assets include laptop and office equipment.